Does ABALOPARATIDE Cause Therapy cessation? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Therapy cessation have been filed in association with ABALOPARATIDE (Tymlos). This represents 0.2% of all adverse event reports for ABALOPARATIDE.
55
Reports of Therapy cessation with ABALOPARATIDE
0.2%
of all ABALOPARATIDE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Therapy cessation From ABALOPARATIDE?
Of the 55 reports, 7 (12.7%) required hospitalization, and 1 (1.8%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABALOPARATIDE. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ABALOPARATIDE Alternatives Have Lower Therapy cessation Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY